Fluoro-Checker™
immunoassay analyzer
Easy biomarker determination at the point of care.
Fluoro-Checker ™ is a modern immunoassay analyzer which was developed for the rapid determination of biomarkers at the Point-of-Care. The Fluoro-Checker ™ Reader is operated with user-friendly software and an efficient data management platform and offers cost-effective point-of-care test solutions for primary screening in emergency rooms, hospitals, laboratories and doctor’s offices.
- Highly sensitive and reliable results
- Quantitative and qualitative analyzes
- Intuitive, user-friendly operation
- Extensive connection options
- Automatic system check
- Built-in battery
- No refrigerated items
- Assays stable for 15 months
Available tests.
AMI cTnl
- 80 µL sample volume
- 15 min. Analysis time
- Quantitatively
- Whole blood, plasma, serum
- 03-30 ng / mL
PCT
- WB: 20 µL, plasma / serum: 10 µL
- 15 min. Analysis time
- Quantitatively
- Whole blood, plasma, serum
- 07-30 ng / mL
D-Dimer
- VB: 10 µL, plasma: 5 µL
- 15 min. Analysis time
- Quantitatively
- Whole blood, plasma
- 120 – 4400 ng / mL
Beta-hCG
- 80 µL sample volume
- 10 min. Analysis time
- Quantitatively
- Whole blood, plasma
- 2-500 mIU / mL
NT-proBNP
- 80 µL sample volume
- 15 min. Analysis time
- Quantitatively
- Whole blood, plasma, serum
- 20-12800 pg / mL
AMI 3 IN 1 (cTnl, CK-MB, Myoglobin)
- 80 µL sample volume
- 15 min. Analysis time
- Quantitatively
- Whole blood, plasma, serum
- cTnl: 0.03 – 30 ng / mL
- CK – MB: 2 – 200 ng / mL
- Myoglobin: 10 – 500 ng / mL
iFOB
- 80 µL sample volume
- 5 min. Analysis time
- Quantitatively
- chair
- 25-1000 ng / mL
Influenza A+B
- 10 min. Analysis time
- Qualitatively
- Nasal swab
CRP
- 2 µL sample volume
- 5 min. Analysis time
- Quantitatively
- Whole blood, plasma, serum
- 1-150 μg / mL
Technology
Highly sensitive and reliable results.
Fluoro-Checker ™ offers reliable and highly sensitive results for a variety of important biomarkers, both quantitatively and qualitatively, thanks to the latest immunoassay technology with colloidal gold.
Extensive connection options.
Thanks to its connection options, Fluoro-Checker ™ can also be integrated into your LIS or HIS so that you have access to your measurement results at any time.
Intuitive and user-friendly operation.
With its user-friendly interface, Fluoro-Checker ™ offers a simple operating concept that helps you to further optimize your workflow.
Do you have any questions about our immunoassay analyzers?
Specifications
Fluoro-Checker™
The most important specifications of the Fluoro-Checker ™ immunoassay analyzer.
System
OS: Linux
Storage
> 10.000 Tests
Quality control / calibration
Internal Quality Control (IQC)
Dimensions
W 30 cm x D 21 cm x H 19.1 cm
Registration
CE
Manufacturer
Country of production
USA
Power supply
Mains operation and battery
Features
Touchscreen, barcode scanner (optional), battery, printer, 4x USB / Ethernet
May we help you?
More immunoassay analyzer and Point-of-care systems.
- Colloidal Gold-Based Immunochromatography
- 9 different assays available
- Highly sensitive and reliable results
- Extensive connection options
- Automatic system check
- Quantitative and qualitative analyzes
- No chilled goods
- Assays stable for 12 months
- 22 measured parameters
- Including iMg, BUN and creatinine
- Reliable and precise results
- Extensive connectivity options
- Automated QC system
Posts related to this immunoassay analyzer.
Article:
An immounassay is a bioanalytical method that uses the binding specificity of an antigen-antibody reaction to measure the presence or concentration of an analyte in a biological sample. Immunoassays are used in clinical laboratories, for drug detection or monitoring, and for food testing, among other things.
Article:
Up to 75% of all problems that lead to incorrect measurement results can be traced back to inadequate preanalytics. Nevertheless, in practice, very often too little attention is paid to pre-analytical errors. A pre-analytical error can cause an incorrect result for one parameter while not affecting other parameters.
Article:
Detecting and treating sepsis has gained high priority in intensive care worldwide and is a quality mark for some health systems.